Enable Accessibility Enable Accessibility

Quarterly Results FY2021 (April 2021-March 2022)

Earnings announcement for the first quarter FY2021 (July 30, 2021)

Webcast for Investors, Analysts and Media, 7:00pm-8:00pm JST (Presentation and Q&A Session)

Participants:     

  • Christophe Weber, President and Chief Executive Officer
  • Costa Saroukos, Chief Financial Officer
  • Andy Plump, President, Research & Development and others

 

Document Q1
Press Release PDF.png
Presentation (for Investors) PDF.png
Quarterly Financial Report PDF.png
  (Supplementary Information) Reconciliation from Reported to Core/Underlying Core microphone.png

(Supplementary Information) Supplementary Financial Information

microphone.png

Webcast for Investors, Analysts and Media (Presentation and Q&A Session)

microphone.png
Financial Statements (Tokyo Stock Exchange filing) PDF.png
Annual Securities Report / Quarterly Securities Report * -
Clinical Trial Summary PDF.png


* The English version of the Annual Securities Report/Quarterly Securities Report is provided as a reference material to assist foreign inventors in understanding the Securities Report, which was filed with Japanese FSA (Financial Services Agency). We do not provide assurance about the accuracy, validity, or coverage of the English translation of this document, and if the description and explanation of this document differs from those of the Japanese Annual Securities Report/Quarterly Securities Report which was filed, the Securities Report in Japanese shall prevail.